Type: rating_growth

Analysts Morgan Stanley upgraded Merck & Co. (MRK) to Overweight and raised target price to $179, citing strong cancer drug pipeline

08/20/2026, 05:37 AM investing rating_growth Analysts: analysts, Morgan Stanley healthcare

Morgan Stanley has upgraded Merck's stock to overweight, citing confidence in its drug pipeline to sustain growth despite the impending expiration of the Keytruda patent in 2028. The firm raised its price target for Merck shares to $179, indicating a potential 17% upside.

Analysts Morgan Stanley upgraded Honeywell Aerospace (HONA) to Overweight with a target price of $205, indicating upside of nearly 28%

08/19/2026, 05:36 AM investing rating_growth Analysts: analysts, Morgan Stanley industrials

Morgan Stanley has upgraded Honeywell Aerospace to overweight, citing its current undervaluation and a price target of $205, which suggests a potential upside of nearly 28%. This recommendation comes despite ongoing concerns about the company's growth and operational challenges.

Analysts Wells Fargo, Leerink Partners, and Guggenheim Initiate Coverage of Scribe Therapeutics (SCTX) with Target Prices Indicating Significant Upside Potential

08/18/2026, 07:36 AM investing rating_growth Analysts: analysts, Wells Fargo, Guggenheim, Leerink Partners biotech

Analysts are optimistic about Scribe Therapeutics' growth potential following its recent IPO, with price targets suggesting significant upside for investors. The company's innovative gene-editing technologies position it favorably in the competitive biotech landscape.

Analysts D.A. Davidson upgraded Duolingo (DUOL) to Buy and raised target price to $160 (upside +23%)

08/18/2026, 05:37 AM investing rating_growth Analysts: analysts software

D.A. Davidson has upgraded Duolingo to a 'buy' rating, citing signs of a turnaround in its core business and a potential 23% upside in the stock price, despite recent struggles with subscriber growth and market concerns.

Analysts TD Cowen raised price targets for CrowdStrike (CRWD) to $235 and Palo Alto Networks (PANW) to $400 amid strong cybersecurity demand driven by AI

08/17/2026, 09:37 AM economy rating_growth Analysts: analysts, TD Cowen software ai

Jim Cramer emphasizes that investors should remain optimistic about cybersecurity stocks like CrowdStrike and Palo Alto, which have seen significant gains this year due to increasing demand driven by AI-related threats.

Analysts Wells Fargo initiated coverage of Huntington Bancshares (HBAN) with an overweight rating and $23 target price, indicating 28% upside

08/17/2026, 08:36 AM investing rating_growth Analysts: analysts, Wells Fargo finance

Wells Fargo has initiated coverage of Huntington Bancshares with an overweight rating and a price target of $23, indicating a potential upside of approximately 28% from its recent closing price of $17.91.

Analysts Jefferies initiate coverage of Freenome (FRNM) with a Buy rating and $17 target price, indicating 47% upside

08/17/2026, 08:36 AM investing rating_growth Analysts: analysts, Jefferies healthcare

Freenome is set to launch its cancer-screening services this fall, with Jefferies initiating coverage and projecting a 47% upside for the stock, indicating strong potential for growth in the cancer detection market.

Analysts Wells Fargo upgraded Okta (OKTA) to overweight and raised target price to $180, citing strong demand for identity services

08/17/2026, 06:36 AM investing rating_growth Analysts: analysts, Wells Fargo software

Wells Fargo has upgraded Okta's stock rating, citing strong demand for identity management services and a significant upside potential for investors. The bank's analysis suggests that Okta's shares could rise by 22% over the next year.

Analysts Piper Sandler initiated coverage of SoFi Technologies (SOFI) with an overweight rating and a $22 price target, indicating 20% upside

08/17/2026, 05:37 AM investing rating_growth Analysts: analysts, Piper Sandler finance

Piper Sandler has initiated coverage of SoFi Technologies with an overweight rating and a $22 price target, indicating a potential 20% upside, highlighting the company's growth prospects in lending and debt consolidation.

Analysts Rothschild & Co upgraded Apple (AAPL) to Buy with $400 target price, citing potential for foldable iPhone

08/17/2026, 04:36 AM investing rating_growth Analysts: analysts, Rothschild & Co software

Rothschild & Co. has upgraded Apple to a buy rating, highlighting the potential of a forthcoming foldable iPhone, which could significantly enhance the company's market position and sales figures.